​

Dianthus Therapeutics (DNTH) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Dianthus Therapeutics Revenue Highlights

Latest Revenue (Y)

$2.04M

Latest Revenue (Q)

$193.00K

Main Segment (Y)

License

Dianthus Therapeutics Revenue by Period

Dianthus Therapeutics Revenue by Year

DateRevenueChange
2025-12-31$2.04M-67.35%
2024-12-31$6.24M120.63%
2023-12-31$2.83M-55.96%
2022-12-31$6.42M334.76%
2021-12-31$1.48M100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31--

Dianthus Therapeutics generated $2.04M in revenue during NA 2025, up -67.35% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Dianthus Therapeutics Revenue by Quarter

DateRevenueChange
2025-06-30$193.00K-83.40%
2025-03-31$1.16M-12.29%
2024-12-31$1.33M-38.95%
2024-09-30$2.17M16.59%
2024-06-30$1.86M113.16%
2024-03-31$874.00K91.25%
2023-12-31$457.00K-50.54%
2023-09-30$924.00K-4.64%
2023-06-30$969.00K103.57%
2023-03-31$476.00K-59.49%
2022-12-31$1.18M0.17%
2022-09-30$1.17M100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--

Dianthus Therapeutics generated $193.00K in revenue during Q2 2025, up -83.40% compared to the previous quarter, and up 22.08% compared to the same period a year ago.

Dianthus Therapeutics Revenue Breakdown

Dianthus Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24
License$2.04M$326.00K

Dianthus Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 25: License (100.00%).

Quarterly Revenue by Product

Product/ServiceDec 25Sep 25Jun 25
License$1.45M$396.00K$193.00K

Dianthus Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: License (100.00%).

Dianthus Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ANABAnaptysBio$234.60M$76.32M
NKTRNektar Therapeutics$55.23M$11.79M
IMTXImmatics$54.00M$30.45M
TSHATaysha Gene Therapies$9.77M-
DNTHDianthus Therapeutics$2.04M$193.00K
OCSOculis$883.00K-
ATAIAtai Beckley N.V-$749.00K
ELVNEnliven Therapeutics--
BBOTBridgeBio Oncology Therapeutics--
TRMLTourmaline Bio--
SANASana Bio--

DNTH Revenue FAQ

What is Dianthus Therapeutics’s yearly revenue?

Dianthus Therapeutics's yearly revenue for 2025 was $2.04M, representing a decrease of -67.35% compared to 2024. The company's yearly revenue for 2024 was $6.24M, representing an increase of 120.63% compared to 2023. DNTH's yearly revenue for 2023 was $2.83M, representing a decrease of -55.96% compared to 2022.

What is Dianthus Therapeutics’s quarterly revenue?

Dianthus Therapeutics's quarterly revenue for Q2 2025 was $193K, a -83.40% decrease from the previous quarter (Q1 2025), and a -89.64% decrease year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $1.16M, a -12.29% decrease from the previous quarter (Q4 2024), and a 33.07% increase year-over-year (Q1 2024). DNTH's quarterly revenue for Q4 2024 was $1.33M, a -38.95% decrease from the previous quarter (Q3 2024), and a 190.15% increase year-over-year (Q4 2023).

What is Dianthus Therapeutics’s revenue growth rate?

Dianthus Therapeutics's revenue growth rate for the last 3 years (2023-2025) was -27.95%, and for the last 5 years (2021-2025) was 37.94%.

What are Dianthus Therapeutics’s revenue streams?

Dianthus Therapeutics's revenue streams in c 25 are License

What is Dianthus Therapeutics’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Dianthus Therapeutics was License. This segment made a revenue of $2.04M, representing 100.00% of the company's total revenue.